More clinically relevant disease models with endogenous levels of SOD1 expression are necessary in order to accurately define the role of SOD1 in the pathogenesis of ALS, especially in the context of protein aggregation. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.